Abstract
To investigate the onset of action of olopatadine HCl nasal spray 0.6% (OLO) relative to vehicle when given to patients with allergic rhinitis in an Environmental Exposure Chamber (EEC) as a single dose.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
